EXECUTIVE ENGAGEMENTS
POOL
3029
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
543
Interactions with Platform & by Email
PARTICIPANTS
91
Unique # Participated
VALIDATIONS
26
Responses Validated*
COMPANIES
46
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
123
PAGES
196
EDITION
8
PRICE
USD 4950
CODE
MCP16418
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global Gene Delivery Systems Market to Reach $4.5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Gene Delivery Systems estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$4.5 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Viral Gene, one of the segments analyzed in the report, is projected to record a 6.9% CAGR and reach US$3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Non-Viral Gene segment is readjusted to a revised 6.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $844.5 Million, While China is Forecast to Grow at 6% CAGR
The Gene Delivery Systems market in the U.S. is estimated at US$844.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$794.3 Million by the year 2027 trailing a CAGR of 6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
Combined Hybrid Segment to Record 4.4% CAGR
In the global Combined Hybrid segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$227.8 Million in the year 2020 will reach a projected size of US$309.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
SELECT PLAYERS
Amgen, Inc.; Bayer AG; Human Stem Cells Institute; Johnson & Johnson; Novartis AG; Oxford Biomedica plc; Pfizer, Inc.; Shanghai Sunway Biotech Co., Ltd.; Sibiono GeneTech Co. Ltd.
SEGMENTS
» Delivery (Viral Gene, Non-Viral Gene, Combined Hybrid) » Application (Oncology, CNS, Infectious Diseases, Ophthalmology, Diabetes, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Gene Delivery Systems – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Gene Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Gene Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Gene Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Viral Gene Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Viral Gene Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Viral Gene Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Non-viral Gene Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Non-viral Gene Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Non-viral Gene Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for CVD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for CVD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for CVD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Urology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Urology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Urology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for CNS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for CNS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for CNS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Injectable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Inhalation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Inhalation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Inhalation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Transdermal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Transdermal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Transdermal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ocular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Gene Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Gene Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| JAPAN |
| Gene Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| CHINA |
| Gene Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| EUROPE |
| Gene Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for Gene Delivery Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Gene Delivery Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Gene Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| FRANCE |
| Gene Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| GERMANY |
| Gene Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| Gene Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| Gene Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com